MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
In this review, the potential future role of microRNA-based therapies and their specific application in lung diseases is reported with special attention to pulmonary hypertension. Current limitations of these therapies will be pointed out in order to address the challenges that they need to face to...
Main Authors: | Susana Carregal-Romero, Lucía Fadón, Edurne Berra, Jesús Ruíz-Cabello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/9/3253 |
Similar Items
-
Targeting MicroRNA Function in Respiratory Diseases: Mini-review
by: Steven eMaltby, et al.
Published: (2016-02-01) -
miRacle of microRNA-Driven Cancer Nanotherapeutics
by: Goknur Kara, et al.
Published: (2022-08-01) -
MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms
by: Abhijeet A. Bakre, et al.
Published: (2019-05-01) -
Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations
by: Fiona T van den Berg, et al.
Published: (2016-01-01) -
The Multifaceted Roles of MicroRNAs in Cystic Fibrosis
by: Fatima Domenica Elisa De Palma, et al.
Published: (2020-12-01)